Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignant neoplasms, and its prognosis is very poor if diagnosed late, therefore, early detection is important. As we know not all HCC can secrete AFP, and AFP levels may be normal in as many as 40% of patients with early HCC and 15%-20% of patients with advanced HCC[1]. Therefore, we selected AFP, alpha-L-fucosidase (AFU) and sialic acid (SA) in combination for detecting HCC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have